190 related articles for article (PubMed ID: 33015770)
1. Long non-coding RNA LINC00173 serves as sponge for miR-338-3p to promote prostate cancer progression via regulating Rab25.
Hu CH; Yang XJ; Yu L; Wang LY; Zhao XC; Han CH
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9290-9302. PubMed ID: 33015770
[TBL] [Abstract][Full Text] [Related]
2. LncRNA HOXA11-AS promotes cell growth by sponging miR-24-3p to regulate JPT1 in prostate cancer.
Cheng Y; Xiong HY; Li YM; Zuo HR; Liu Y; Liao GL
Eur Rev Med Pharmacol Sci; 2021 Jul; 25(14):4668-4677. PubMed ID: 34337714
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA long intergenic non-protein-coding RNA 173 contributes to nasopharyngeal carcinoma progression by regulating microRNA-765/Gremlin 1 pathway.
Wang D; Jiang H
Hum Exp Toxicol; 2023; 42():9603271231172921. PubMed ID: 37365917
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding TUG1 accelerates prostate cancer progression through regulating miR-128-3p/YES1 axis.
Hao SD; Ma JX; Liu Y; Liu PJ; Qin Y
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):619-632. PubMed ID: 32016963
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNA SNHG14 promotes malignancy of prostate cancer by regulating with miR-5590-3p/YY1 axis.
Luo ZF; Peng Y; Liu FH; Ma JS; Hu G; Lai SL; Lin H; Chen JJ; Zou GM; Yan Q; Sui WG
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):4697-4709. PubMed ID: 32432733
[TBL] [Abstract][Full Text] [Related]
6. LncRNA SNHG15 acts as an oncogene in prostate cancer by regulating miR-338-3p/FKBP1A axis.
Zhang Y; Zhang D; Lv J; Wang S; Zhang Q
Gene; 2019 Jul; 705():44-50. PubMed ID: 30981837
[TBL] [Abstract][Full Text] [Related]
7. PAX5-induced upregulation of LINC01194 exerts oncogenic properties by regulating GOLPH3 expression via miR-486-5p in prostate cancer.
Song HR; Guo XB; Duan Y; Meng HY; Wang ZY
Eur Rev Med Pharmacol Sci; 2021 Mar; 25(6):2528-2541. PubMed ID: 33829439
[TBL] [Abstract][Full Text] [Related]
8. LINC00641 regulates prostate cancer cell growth and apoptosis via the miR-365a-3p/VGLL4 axis.
Liu WH; Lu JJ; Yu RK; Zhou L; Yu Q; Li DF; Zhu QH
Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):108-115. PubMed ID: 33506898
[TBL] [Abstract][Full Text] [Related]
9. PCGEM1 promotes proliferation, migration and invasion in prostate cancer by sponging miR-506 to upregulate TRIAP1.
Liu H; He X; Li T; Qu Y; Xu L; Hou Y; Fu Y; Wang H
BMC Urol; 2022 Feb; 22(1):14. PubMed ID: 35109849
[TBL] [Abstract][Full Text] [Related]
10. LncRNA LINC00173 enhances triple-negative breast cancer progression by suppressing miR-490-3p expression.
Fan H; Yuan J; Li X; Ma Y; Wang X; Xu B; Li X
Biomed Pharmacother; 2020 May; 125():109987. PubMed ID: 32058222
[TBL] [Abstract][Full Text] [Related]
11. LncRNA HOXA-AS2 promotes the progression of prostate cancer via targeting miR-509-3p/PBX3 axis.
Xiao S; Song B
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32519740
[TBL] [Abstract][Full Text] [Related]
12. A review on the role of LINC00173 in human cancers.
Ghafouri-Fard S; Safarzadeh A; Hussen BM; Rasul MF; Taheri M; Akbari Dilmaghani N
Pathol Res Pract; 2023 Mar; 243():154351. PubMed ID: 36774758
[TBL] [Abstract][Full Text] [Related]
13. LINC00173.v1 promotes angiogenesis and progression of lung squamous cell carcinoma by sponging miR-511-5p to regulate VEGFA expression.
Chen J; Liu A; Wang Z; Wang B; Chai X; Lu W; Cao T; Li R; Wu M; Lu Z; Pang W; Xiao L; Chen X; Zheng Y; Chen Q; Zeng J; Li J; Zhang X; Ren D; Huang Y
Mol Cancer; 2020 May; 19(1):98. PubMed ID: 32473645
[TBL] [Abstract][Full Text] [Related]
14. Long noncoding RNA LINC00662 functions as miRNA sponge to promote the prostate cancer tumorigenesis through targeting miR-34a.
Li N; Zhang LY; Qiao YH; Song RJ
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3688-3698. PubMed ID: 31114993
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA NORAD promotes the prostate cancer cell extracellular vesicle release via microRNA-541-3p-regulated PKM2 to induce bone metastasis of prostate cancer.
Hu CY; Chen J; Qin XH; You P; Ma J; Zhang J; Zhang H; Xu JD
J Exp Clin Cancer Res; 2021 Mar; 40(1):98. PubMed ID: 33722248
[TBL] [Abstract][Full Text] [Related]
16. Involvement of aberrantly activated HOTAIR/EZH2/miR-193a feedback loop in progression of prostate cancer.
Ling Z; Wang X; Tao T; Zhang L; Guan H; You Z; Lu K; Zhang G; Chen S; Wu J; Qian J; Liu H; Xu B; Chen M
J Exp Clin Cancer Res; 2017 Nov; 36(1):159. PubMed ID: 29141691
[TBL] [Abstract][Full Text] [Related]
17. MALAT1 knockdown inhibits prostate cancer progression by regulating miR-140/BIRC6 axis.
Hao T; Wang Z; Yang J; Zhang Y; Shang Y; Sun J
Biomed Pharmacother; 2020 Mar; 123():109666. PubMed ID: 31935634
[TBL] [Abstract][Full Text] [Related]
18. LncRNA CCAT1 promotes prostate cancer cells proliferation, migration, and invasion through regulation of miR-490-3p/FRAT1 axis.
Cai X; Dai Y; Gao P; Ren G; Cheng D; Wang B; Wang Y; Yu J; Du Y; Wang X; Xue B
Aging (Albany NY); 2021 Jul; 13(14):18527-18544. PubMed ID: 34319909
[TBL] [Abstract][Full Text] [Related]
19. LncRNA GAPLINC promotes the growth and metastasis of glioblastoma by sponging miR-331-3p.
Chen HH; Zong J; Wang SJ
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):262-270. PubMed ID: 30657584
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1.
Li X; Han X; Wei P; Yang J; Sun J
Cancer Biol Ther; 2020 May; 21(5):452-462. PubMed ID: 32089062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
